Training cover

Spirometry and Feno, Important diagnostic and monitoring tools for the Asthmatic patient.


Free


Diffusion

Online

Vyaire Medical

4.6

· 4413 Reviews

See the catalog
About Speakers Audience Reviews

About

500 seats per session

English

There is increasing evidence that asthma is a heterogeneous pathological condition characterized by different phenotypes/endotypes related to specific pathological pathways. Exhaled nitric oxide (FeNO), is a biomarker of one pathologic pathway, allergic airway inflammation, that has proven helpful to predict therapeutic response in selected asthmatic populations. FeNO is a quantitative, non-invasive, simple and safe method of measuring allergic airway inflammation that provides a complementary tool to other ways of assessing airway disease in asthma patients including spirometry and as part of the diagnostic algorithm for both children over 5 and adults with respiratory symptoms suggestive of asthma, but has also demonstrated utility for managing asthma and selecting therapies for this disease. A common question is “How do FeNO and spirometry complement each other and why do I need both?” 

During this webinar, our speaker Dr. Philip E Silkoff will try and answer this question by reviewing the current evidence on the relationship between FeNO & Spirometry and how these tools can be used together for the Asthmatic patients. 

Respiratory Therapists, PFT Therapists, Quality Therapists

Speakers icon

Speakers

Speaker Avatar
Dr. Philip Silkoff Senior clinical trial executive
Target audience icon

Audience

This event is for specialists below

Pulmonology

Respiratory Therapist

Reviews icon

What you peers think about Vyaire Medical

13/05/2022

Emily L.

4


13/05/2022

Sarel V.

4


13/05/2022

Hung N.

5


13/05/2022

Simone C.

4


13/05/2022

Jorge A.

5


13/05/2022

Ewa N.

5

Contact icon

Contact us

Chat with us

- Chat available in the bottom left corner